𝔖 Bobbio Scriptorium

✦ LIBER ✦

Osteosclerotic lesions in patients treated with gefitinib for lung adenocarcinomas: a sign of favorable therapeutic response

✍ Scribed by Yoshiko Yamashita; Takatoshi Aoki; Takeshi Hanagiri; Chiharu Yoshii; Hiroshi Mukae; Hidetaka Uramoto; Yukunori Korogi

Book ID: 105959463
Publisher: Springer
Year: 2011
Tongue: English
Weight: 283 KB
Volume: 41
Category: Article
ISSN: 0364-2348
DOI: 10.1007/s00256-011-1253-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Skin rash by gefitinib is a sign of favo

Skin rash by gefitinib is a sign of favorable outcomes for patients of advanced lung adenocarcinoma in Japanese patients

✍ Yasoo Sugiura, Etsuo Nemoto, Osamu Kawai, Yasuyuki Ohkubo, Hisae Fusegawa… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 164 KB

Predictive Factors for Interstitial Lung

Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib

✍ Ando, M. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 294 KB

Asian ethnicity and adenocarcinoma histo

Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America

✍ Ho, Cheryl; Murray, Nevin; Laskin, Janessa; Melosky, Barbara; Anderson, Helen; B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 164 KB

P-471 The predictive value of serum tumo

P-471 The predictive value of serum tumor marker response in gefitinib-treated non-small cell lung cancer patients with or without measurable radiographic lesions

✍ Chiu, C.; Shih, Y.; Tsai, C.; Perng, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Asian Ethnicity as a Predictor of Respon

Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program

✍ Sheeba K. Thomas; Frank V. Fossella; Diane Liu; Rainell Schaerer; Anne S. Tsao; 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 898 KB

A Randomized Phase II Study of Gefitinib

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

✍ Han, J.-Y.; Lee, S.-H.; Yoo, N. J.; Hyung, L. S.; Moon, Y. J.; Yun, T.; Kim, H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB